Antonio Omuro

Antonio Omuro

UNVERIFIED PROFILE

Are you Antonio Omuro?   Register this Author

Register author
Antonio Omuro

Antonio Omuro

Publications by authors named "Antonio Omuro"

Are you Antonio Omuro?   Register this Author

100Publications

3116Reads

10Profile Views

Applications of artificial intelligence in neuro-oncology.

Curr Opin Neurol 2019 Oct 10. Epub 2019 Oct 10.

Yale Brain Tumor Center at Yale Cancer Center and Smilow Cancer Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000761DOI Listing
October 2019

Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.

Am J Hematol 2019 Apr 4;94(4):455-460. Epub 2019 Feb 4.

Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25414DOI Listing
April 2019

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.

J Clin Oncol 2018 06 23;36(17):1702-1709. Epub 2018 Apr 23.

Antonio Omuro, University of Miami, Miami, FL; Kathryn Beal, Robert J. Young, Thomas J. Kaley, Lisa M. DeAngelis, Mariza Daras, Igor T. Gavrilovic, Ingo Mellinghoff, Eli L. Diamond, Andrew McKeown, Malbora Manne, Andrew Caterfino, Krishna Patel, Philip Gutin, Viviane Tabar, Debyani Chakravarty, Timothy A. Chan, Cameron W. Brennan, and Elena Pentsova, Memorial Sloan Kettering Cancer Center; Rashida A. Karmali, Tactical Therapeutics, Inc, New York; Katharine McNeill, Montefiore Medical Center, Bronx, NY; Alissa Thomas, University of Vermont, Burlington, VT; Xuling Lin, National Neuroscience Institute, Singapore; Robert Terziev, University Hospital, Zurich, Switzerland; Linda Bavisotto, Porta Clinica PLLC, Seattle, WA; Greg Gorman, Samford University McWhorter School of Pharmacy, Birmingham, AL; Michael Lamson, Nuventra Pharma Sciences, Durham, NC; and Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.9992
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.9992DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993168PMC
June 2018

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of F-(2S,4R)-4-Fluoroglutamine.

Radiology 2018 05 31;287(2):667-675. Epub 2018 Jan 31.

From the Department of Radiology (M.P.S.D., W.W., J.S.L.), Department of Medicine (J.J.H., J.B., A.M.O., J.J.H., I.K.M., J.F.G., D.P.K.), Radiochemistry and Molecular Imaging Probe Core (H.Z., E.M.B., S.K.L., J.S.L.), and Department of Medical Physics (B.J.B., P.B.Z.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room S113E, New York, NY 10065; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY (H.Z., K.S., J.S.L.); Department of Radiology, Weill-Cornell Medical College, New York, NY (M.P.S.D., W.W., J.S.L.); Laboratory of Neural Systems, the Rockefeller University, New York, NY (C.P.); Department of Pathology, University of Michigan, Ann Arbor, Mich (S.V.); and Departments of Radiology and Pharmacology, University of Pennsylvania, Philadelphia, Pa (H.F.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017162610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929369PMC
May 2018

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab.

CNS Oncol 2018 01 1;7(1):7-13. Epub 2018 Feb 1.

Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2017-0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001559PMC
January 2018

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Neuro Oncol 2017 Oct;19(10):1380-1390

Memorial Sloan Kettering Cancer Center, New York, New York,USA; Northwestern Memorial Hospital, Chicago, Illinois, USA; NorthShore University, Evanston, Illinois,USA; University of Calgary, Calgary, Alberta, Canada; Massachusetts General Hospital, Boston, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596171PMC
October 2017

Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.

Neuro Oncol 2017 Sep;19(9):1248-1254

Department of Neurology, Department of Laboratory Medicine, Department of Pathology, and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570249PMC
September 2017

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 08;23(8):1004

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0817-1004cDOI Listing
August 2017

OncoKB: A Precision Oncology Knowledge Base.

JCO Precis Oncol 2017 Jul 16;2017. Epub 2017 May 16.

, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Gynecologic Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Head and Neck Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , , Department of Hematology and Oncology, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA; , Department of R&D and Bioinformatics, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA; , Head and Neck Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Gynecologic Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Sarcoma Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Sarcoma Medical Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA , Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; , Breast Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Weill Cornell Medical College, New York, NY USA; , Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://www.researchgate.net/profile/Debyani_Chakravarty/pub
Web Search
http://ascopubs.org/doi/10.1200/PO.17.00011
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586540PMC
http://dx.doi.org/10.1200/PO.17.00011DOI Listing
July 2017

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:
Ahmet Zehir Ryma Benayed Ronak H Shah Aijazuddin Syed Sumit Middha Hyunjae R Kim Preethi Srinivasan Jianjiong Gao Debyani Chakravarty Sean M Devlin Matthew D Hellmann David A Barron Alison M Schram Meera Hameed Snjezana Dogan Dara S Ross Jaclyn F Hechtman Deborah F DeLair JinJuan Yao Diana L Mandelker Donavan T Cheng Raghu Chandramohan Abhinita S Mohanty Ryan N Ptashkin Gowtham Jayakumaran Meera Prasad Mustafa H Syed Anoop Balakrishnan Rema Zhen Y Liu Khedoudja Nafa Laetitia Borsu Justyna Sadowska Jacklyn Casanova Ruben Bacares Iwona J Kiecka Anna Razumova Julie B Son Lisa Stewart Tessara Baldi Kerry A Mullaney Hikmat Al-Ahmadie Efsevia Vakiani Adam A Abeshouse Alexander V Penson Philip Jonsson Niedzica Camacho Matthew T Chang Helen H Won Benjamin E Gross Ritika Kundra Zachary J Heins Hsiao-Wei Chen Sarah Phillips Hongxin Zhang Jiaojiao Wang Angelica Ochoa Jonathan Wills Michael Eubank Stacy B Thomas Stuart M Gardos Dalicia N Reales Jesse Galle Robert Durany Roy Cambria Wassim Abida Andrea Cercek Darren R Feldman Mrinal M Gounder A Ari Hakimi James J Harding Gopa Iyer Yelena Y Janjigian Emmet J Jordan Ciara M Kelly Maeve A Lowery Luc G T Morris Antonio M Omuro Nitya Raj Pedram Razavi Alexander N Shoushtari Neerav Shukla Tara E Soumerai Anna M Varghese Rona Yaeger Jonathan Coleman Bernard Bochner Gregory J Riely Leonard B Saltz Howard I Scher Paul J Sabbatini Mark E Robson David S Klimstra Barry S Taylor Jose Baselga Nikolaus Schultz David M Hyman Maria E Arcila David B Solit Marc Ladanyi Michael F Berger

Nat Med 2017 Jun 8;23(6):703-713. Epub 2017 May 8.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nm.4333
Publisher Site
http://dx.doi.org/10.1038/nm.4333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461196PMC
June 2017

Long-term survival in AIDS-related primary central nervous system lymphoma.

Neuro Oncol 2017 01 30;19(1):99-108. Epub 2016 Aug 30.

Division of Hematology/Oncology, University of California, San Francisco (N.K.G., C.W., G.M., D.I.A., L.D.K., J.A.L., P.V., J.L.R.); Department of Pathology, University of California, San Francisco (A.N., P.A.T.); Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY (A.O.); Division of Hematology/Oncology, University of California, San Diego (E.G.R.); Division of Hematology/Oncology, San Francisco General Hospital (C.W., D.I.A., J.A.L.); Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL (M.J., J.C.C.); Department of Medicine, Section of Hematology/Oncology, John H. Stroger Jr. Hospital of Cook County, Ruth M. Rothstein CORE Center, Developmental Center for AIDS Research, Chicago, IL (P.G.R.); Department of Internal Medicine, Rush University Medical Center, Chicago, IL (P.G.R.); UCSF Cancer Registry, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (A.G.); Helen Diller Family Comprehensive Cancer Center, University of California San Francisco (D.I.A., J.H., L.D.K., J.A.L., P.V., P.A.T., J.L.R.); Biostatistics and Computational Biology Core, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (J.H.); Center for AIDS Research; UCSF Gladstone Institute of Virology and Immunology (P.V.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193026PMC
January 2017

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.

Biol Blood Marrow Transplant 2017 01 3;23(1):38-43. Epub 2016 Oct 3.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.09.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518313PMC
January 2017

Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.

Ophthalmology 2016 09 29;123(9):2047-50. Epub 2016 Apr 29.

Ophthalmology Department, DHU SightRestore, Pitie-Salpetriere Hospital, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2016.03.043DOI Listing
September 2016

High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.

Leuk Lymphoma 2016 08 4;57(8):1961-4. Epub 2016 Jan 4.

a Department of Neurology , Memorial Sloan Kettering Cancer Center , New York , NY , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1120867DOI Listing
August 2016

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.

J Clin Oncol 2016 07 9;34(20):2404-15. Epub 2016 May 9.

Elena I. Pentsova, Ronak H. Shah, Jiabin Tang, Adrienne Boire, Daoqi You, Samuel Briggs, Antonio Omuro, Xuling Lin, Martin Fleisher, Christian Grommes, Katherine S. Panageas, Fanli Meng, S. Duygu Selcuklu, Shahiba Ogilvie, Natalie Distefano, Larisa Shagabayeva, Marc Rosenblum, Lisa M. DeAngelis, Agnes Viale, Ingo K. Mellinghoff, and Michael F. Berger, Memorial Sloan Kettering Cancer Center; Ingo K. Mellinghoff, Weill-Cornell Graduate School of Biomedical Sciences; and Michael F. Berger, Weill-Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981784PMC
July 2016

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Authors:
Vijay Ramaswamy Thomas Hielscher Stephen C Mack Alvaro Lassaletta Tong Lin Kristian W Pajtler David T W Jones Betty Luu Florence M G Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E McLendon Eric S Lipp Christopher Dunham Juliette Hukin David D Eisenstat Dorcas Fulton Frank K H van Landeghem Mariarita Santi Marie-Lise C van Veelen Erwin G Van Meir Satoru Osuka Xing Fan Karin M Muraszko Daniela P C Tirapelli Sueli M Oba-Shinjo Suely K N Marie Carlos G Carlotti Ji Yeoun Lee Amulya A Nageswara Rao Caterina Giannini Claudia C Faria Sofia Nunes Jaume Mora Ronald L Hamilton Peter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Almos Klekner Tibor Hortobágyi Sarah Leary Ralph P Ermoian James M Olson Jeffrey R Leonard Corrine Gardner Wieslawa A Grajkowska Lola B Chambless Jason Cain Charles G Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca R Buttarelli Roger J Packer Lyndsey Emery William H Yong Horacio Soto Linda M Liau Richard Everson Andrew Grossbach Tarek Shalaby Michael Grotzer Matthias A Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M Alonso Teresa Tuñon Ulrich Schüller Karel Zitterbart Jaroslav Sterba Jennifer A Chan Miguel Guzman Samer K Elbabaa Howard Colman Girish Dhall Paul G Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera-Bolanos Khalida Wani Frank Lieberman Tom Mikkelsen Antonio M Omuro Ian F Pollack Michael Prados H Ian Robins Riccardo Soffietti Jing Wu Phillipe Metellus Uri Tabori Ute Bartels Eric Bouffet Cynthia E Hawkins James T Rutka Peter Dirks Stefan M Pfister Thomas E Merchant Mark R Gilbert Terri S Armstrong Andrey Korshunov David W Ellison Michael D Taylor

J Clin Oncol 2016 07 6;34(21):2468-77. Epub 2016 Jun 6.

Vijay Ramaswamy, Stephen C. Mack, Alvaro Lassaletta, Betty Luu, Florence M.G. Cavalli, Uri Tabori, Ute Bartels, Eric Bouffet, Cynthia E. Hawkins, James T. Rutka, Peter Dirks, and Michael D. Taylor, The Hospital for Sick Children; Vijay Ramaswamy, Kenneth Aldape, James T. Rutka, and Michael D. Taylor, University of Toronto; Kenneth Aldape, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario; Christopher Dunham and Juliette Hukin, British Columbia Children's Hospital; Juliette Hukin, University of British Columbia, Vancouver, British Columbia; David D. Eisenstat, Dorcas Fulton, and Frank K.H. van Landeghem, University of Alberta, Edmonton; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Nada Jabado and Kevin Petrecca, McGill University, Montreal, Quebec, Canada; Thomas Hielscher, Kristian W. Pajtler, David T.W. Jones, Marcel Kool, Stefan M. Pfister, and Andrey Korshunov, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Marc Remke, University Hospital Düsseldorf, Düsseldorf; Martin Mynarek, Stefan Rutkowski, and Katja von Hoff, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Schüller, Ludwig-Maximilians-Universität, Munich, Germany; Stephen C. Mack, Cleveland Clinic Foundation, Cleveland; Maryam Fouladi, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Tong Lin, Amar Gajjar, Thomas E. Merchant, and David W. Ellison, St Jude Children's Research Hospital, Memphis; Lola B. Chambless, Vanderbilt Medical Center, Nashville, TN; Sridharan Gururangan, Roger E. McLendon, and Eric S. Lipp, Duke University, Durham; Jing Wu, University of North Carolina at Chapel Hill, Chapel Hill, NC; Mariarita Santi, Children's Hospital of Philadelphia; Lyndsey Emery, Hospital of the University of Pennsylvania, Philadelphia; Ronald L. Hamilton and Ian F. Pollack, University of Pittsburgh School of Medicine; Frank Lieberman, University of Pittsburgh Medical Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962737PMC
July 2016

A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.

Neuro Oncol 2016 06 19;18(6):873-80. Epub 2015 Dec 19.

Department of Radiology, Neuroradiology Service, Memorial Sloan Kettering Cancer Center, New York, New York (V.H., J.R., T.S., K.K.P., R.J.Y.); Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York (T.J.Y., K.B.); Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York (G.U.); Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (A.O., I.G.); Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York (K.M.W., Z.Z.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (K.K.P.); Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York (V.H., A.O., I.G., K.B., R.J.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864262PMC
June 2016

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.

Neuro Oncol 2016 Apr 8;18(4):557-64. Epub 2015 Oct 8.

University of California at San Francisco, San Francisco, California (N.B., A.P., J.P., A.M.M, M.P.); Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.F.D.G.); Department of Neurology, Memorial Sloan Kettering Cancer Hospital, New York, New York (A.M.O.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (L.N., P.Y.W., S.H., K.L.L.); UCLA Medical Center, Los Angeles, California (T.F.C.); Plexxikon Inc., Berkeley, California (A.M., B.L.W., K.B.N., H.H.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Memorial Sloan Kettering Cancer Hospital, New York, New York (J.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799682PMC
April 2016

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.

Neuro Oncol 2016 Feb 20;18(2):283-90. Epub 2015 Dec 20.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724186PMC
February 2016

Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.

Neuro Oncol 2015 Sep 26;17(9):1275-83. Epub 2015 May 26.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA (P.Y.W.); Memorial Sloan Kettering Cancer Center, New York, New York, USA (A.O.); Cleveland Clinic, Cleveland, Ohio, USA (M.S.A.); University of Alabama, Birmingham, Alabama, USA (H.M.F.-S.); University of Rochester Medical Center, Rochester, New York, USA (N.M.); Sanofi, Cambridge, Massachusetts, USA (J.J.L); Exelixis Inc., South San Francisco, California, USA (A.D.L.); Quintiles, Durham, North Carolina, USA (J.T.); Sanofi, Bridgewater, New Jersey, USA (J.J.); Sanofi, Vitry-sur-Seine, France (C.E.); University of California-Los Angeles, Los Angeles, California, USA (T.F.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588757PMC
September 2015

Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient.

Neurology 2015 Aug;85(7):e57-61

From Memorial Sloan Kettering Cancer Center (G.F., E.P., M.R., A.O.), New York; North Shore University Hospital (A.D.), Manhasset, NY; and Groupe Hospitalier Pitié-Salpêtrière (S.T.), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548283PMC
August 2015

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Neuro Oncol 2015 Mar 13;17(3):440-7. Epub 2014 Aug 13.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.V.-B., M.R.G.); Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (K.A., K.W.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (Y.Y., J.W.); Office of Multicenter Clinical Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.J.N.-R.); Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); Departments of Neurology and Medicine (Medical Oncology), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (F.S.L.); Department of Neurosurgery, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France (P.M.); Departments of Neurology & Neurosurgery, Henry Ford Hospital, Detroit, Michigan (T.M.); Department of Neurology, Memorial-Sloan Kettering Cancer Center, New York, New York (A.O.); Department of Neurology, Stanford University & Lucile Packard Children's Hospital, Palo Alto, California (S.P.); Department of Neuro-Oncology, UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California (M.P.); Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (H.I.R.); Department of Neuroscience, University San Giovanni Battista Hospital, Turin, Italy (R.S.); Department of Neurosurgery, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina (J.W.); Department of Family Health, School of Nursing, The University of Texas Health Science Center-Houston, Houston, Texas (T.S.A.); CERN Foundation, Dayton, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483095PMC
March 2015

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Neuro Oncol 2015 Jan 6;17(1):116-21. Epub 2014 Aug 6.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (T.J.K., S.K., A.B.L., C.P.N., L.M.D., I.G., L.E.A., A.O.); Center for Neuro-Oncology, Dana-Farber Cancer Institute/Brigham and Women's Center, Boston, Massachusetts (P.W., K.L., S.H., A.N., J.D., E.Q.L.); Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S., B.P.); Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (S.R.P., T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483051PMC
January 2015

Current role of anti-angiogenic strategies for glioblastoma.

Curr Treat Options Oncol 2014 Dec;15(4):551-66

Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-014-0308-2
Publisher Site
http://dx.doi.org/10.1007/s11864-014-0308-2DOI Listing
December 2014

Emerging therapies for glioblastoma.

JAMA Neurol 2014 Nov;71(11):1437-44

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.1701DOI Listing
November 2014

Transcriptional diversity of long-term glioblastoma survivors.

Neuro Oncol 2014 Sep 23;16(9):1186-95. Epub 2014 Mar 23.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York (N.K.G., A.G., M.R., K.B., Y.Y., T.A.C.); Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (S.T., V.M., K.K., T.A.C.); Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York (A.O.); Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York (P.G., C.W.B.); Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (J.T.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136896PMC
September 2014

Methotrexate re-challenge for recurrent primary central nervous system lymphoma.

J Neurooncol 2014 Mar 31;117(1):161-5. Epub 2014 Jan 31.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-014-1370-0
Publisher Site
http://dx.doi.org/10.1007/s11060-014-1370-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256683PMC
March 2014

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

J Clin Oncol 2013 Nov 7;31(31):3971-9. Epub 2013 Oct 7.

Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Anne S. Reiner, Kathy Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, and Antonio Omuro, Memorial Sloan-Kettering Cancer Center; Rose K. Lai, Columbia University, New York, NY; Jeffrey J. Raizer and Sean Grimm, Northwestern University, Chicago, IL; David Schiff, University of Virginia, Charlottesville, VA; and Barbara Grant, University of Vermont, Burlington, VT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.4910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569679PMC
November 2013

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Neurology 2013 Nov 9;81(19):1690-6. Epub 2013 Oct 9.

From the Massachusetts General Hospital (J.W.T., T.B., R.A.B.), Boston; Mayo Clinic (E.P.F., B.P.O.), Rochester, MN; Hadassah Hebrew University Medical Center (T.S.), Jerusalem, Israel; Memorial Sloan-Kettering (A.O., L.D.), New York, NY; Yale University (J.B.), New Haven, CT; Saitama Medical University (R.N.), Japan; Kings College Hospital (F.P.), London, UK; University of Washington (M.C.), Seattle; LOC National Expert Center (K.H.-X., A.G.-A.), APHP, UPMC, Pitie-Salpetriere, Paris; Centre Leon Berard (J.-Y.B.), Lyon, France; Campus Benjamin Franklin (A.K.), Charite Universitätsmedizin Berlin, Germany; Department of Biostatistics (R.A.B.), Harvard School of Public Health, Boston, MA; and University of Virginia (M.-B.S.L., D.S.), Charlottesville.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000435302.02895.f3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812109PMC
November 2013

Glioblastoma and other malignant gliomas: a clinical review.

JAMA 2013 Nov;310(17):1842-50

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2013.280319DOI Listing
November 2013

Bevacizumab for acute neurologic deterioration in patients with glioblastoma.

CNS Oncol 2013 Sep;2(5):413-8

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.13.40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136096PMC
September 2013

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Breast J 2012 Jul-Aug;18(4):345-50. Epub 2012 May 21.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2012.01246.xDOI Listing
April 2013

Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors.

Neurology 2013 Apr 3;80(17):1598-605; discussion 1603. Epub 2013 Apr 3.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e31828f183fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662321PMC
April 2013

Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.

Neuro Oncol 2012 Oct 5;14(10):1304-11. Epub 2012 Sep 5.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nos207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452344PMC
October 2012

Atypical and anaplastic meningiomas treated with bevacizumab.

J Neurooncol 2012 Aug 29;109(1):187-93. Epub 2012 Apr 29.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0886-4DOI Listing
August 2012

A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.

J Neurooncol 2012 Apr 3;107(2):343-9. Epub 2011 Nov 3.

Princess Margaret Hospital, 610 University Avenue, Suite 18-717, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0747-6DOI Listing
April 2012

Complications of radiotherapy to the central nervous system.

Handb Clin Neurol 2012 ;105:887-901

Service de Neurologie Mazarin, Université Paris VI Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-53502-3.00030-6DOI Listing
April 2012

Prophylactic intrathecal chemotherapy in primary CNS lymphoma.

J Neurooncol 2012 Jan 8;106(1):143-6. Epub 2011 Jul 8.

Service de Neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, 47-83, Boulevard de l'Hôpital, 75651 Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11060-011-0649
Web Search
http://link.springer.com/10.1007/s11060-011-0649-7
Publisher Site
http://dx.doi.org/10.1007/s11060-011-0649-7DOI Listing
January 2012

Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Neuro Oncol 2012 Jan 19;14(1):101-8. Epub 2011 Oct 19.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245999PMC
January 2012

Primary central nervous system lymphoma: is there still a role for radiotherapy?

Curr Opin Neurol 2011 Dec;24(6):633-40

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e32834cbdefDOI Listing
December 2011

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

Leuk Lymphoma 2011 Oct 24;52(10):1891-7. Epub 2011 Jun 24.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.585527DOI Listing
October 2011

Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?

J Neurooncol 2011 Aug 19;104(1):323-30. Epub 2010 Dec 19.

AP-HP, Groupe Hospitalier Pitie-Salpetriere, Service de Neurologie Mazarin, et Universite Pierre & Marie Curie Paris VI, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0497-xDOI Listing
August 2011

Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?

CNS Drugs 2011 Jun;25(6):447-57

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11589030-000000000-00000DOI Listing
June 2011

Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.

J Neurooncol 2011 Feb 17;101(3):457-62. Epub 2010 Jun 17.

AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie Mazarin, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0264-zDOI Listing
February 2011

Brain tumors and dementia.

Handb Clin Neurol 2008 ;89:877-86

Groupe Hospitalier Pitié-Salpêtrière, Federation de Neurologie Mazarin, La Salpêtriere Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0072-9752(07)01277-8DOI Listing
December 2010

Exploring multi-targeting strategies for the treatment of gliomas.

Authors:
Antonio Mp Omuro

Curr Opin Investig Drugs 2008 Dec;9(12):1287-95

Memorial Sloan-Kettering Cancer Center, Department of Neurology, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
December 2008

What is the relevance of determining EGFR-variant-III status in glioblastomas?

Nat Clin Pract Oncol 2008 Apr 4;5(4):188-9. Epub 2008 Mar 4.

Hôpital Pitié-Salpétrière, Division de Neurologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1074DOI Listing
April 2008

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.

J Neurooncol 2008 Mar 7;87(1):85-90. Epub 2007 Nov 7.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9491-3
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9491-3DOI Listing
March 2008

Editorial: what is new in the treatment of gliomas?

Curr Opin Neurol 2007 Dec;20(6):704-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e3282f1beefDOI Listing
December 2007

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.

J Neurooncol 2007 Nov 21;85(2):207-11. Epub 2007 Sep 21.

AP-HP Hopital Pitie-Salpetriere, Service de Neurologie Mazarin, Universite Paris VI Pierre et Marie Curie, IFR 70, Inserm, Unité U711, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9397-0
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9397-0DOI Listing
November 2007

Molecular genetic markers as predictors of response to chemotherapy in gliomas.

Curr Opin Oncol 2007 Nov;19(6):606-11

INSERM, Unité 711, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3282f075f3DOI Listing
November 2007

Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?

Nat Clin Pract Oncol 2007 Sep 10;4(9):514-5. Epub 2007 Jul 10.

Division de Neurologie, Groupe Hospitalier, Pitié-Salpêtrière, Mazarin 47, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0898DOI Listing
September 2007

Lessons learned in the development of targeted therapy for malignant gliomas.

Mol Cancer Ther 2007 Jul;6(7):1909-19

Groupe Hospitalier Pitie-Salpetriere-Federation de Neurologie Mazarin 47, Bd de l'Hopital, 75661 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0047DOI Listing
July 2007

Pitfalls in the diagnosis of brain tumours.

Lancet Neurol 2006 Nov;5(11):937-48

AP-HP Hôpital Pitié-Salpêtrière, Service de Neurologie Mazarin, Universite Paris VI Pierre et Marie Curie, IFR 70, Unite Inserm U711, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(06)70597-XDOI Listing
November 2006

Chemotherapy for primary central nervous system lymphoma.

Neurosurg Focus 2006 Nov 15;21(5):E12. Epub 2006 Nov 15.

Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie Mazarin, 47, Boulevard de l'Hôpital, 75661 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
November 2006

Hypersexuality following bilateral thalamic infarction: case report.

Arq Neuropsiquiatr 2006 Mar 5;64(1):146-8. Epub 2006 Apr 5.

Department of Neurology, School of Medicine, University of São Paulo, São Paulo, SP, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0004-282x2006000100032DOI Listing
March 2006

Salvage temozolomide for prior temozolomide responders.

Cancer 2005 Dec;104(11):2473-6

Department of Medical Oncology, Bellaria Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21564
Publisher Site
http://dx.doi.org/10.1002/cncr.21564DOI Listing
December 2005

Delayed neurotoxicity in primary central nervous system lymphoma.

Arch Neurol 2005 Oct;62(10):1595-600

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneur.62.10.1595DOI Listing
October 2005

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.

Neurology 2005 May;64(9):1625-7

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.WNL.0000160396.69050.DCDOI Listing
May 2005

Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.

Neurology 2005 Jan;64(1):69-74

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.WNL.0000148641.98241.5EDOI Listing
January 2005